Liraglutide Alleviates Hepatic Steatosis by Activating the TFEB-Regulated Autophagy-Lysosomal Pathway

Overview of attention for article published in Frontiers in Cell and Developmental Biology, November 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 30 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 40,672 followers.

RT @DanielJDrucker: Multiple intriguing studies report direct GLP-1R-dependent reduction of hepatocyte steatosis, the latest here #NASH ht…

18 Dec 2020

Reply Repost Favourite

#Liraglutide Alleviates Hepatic #Steatosis by Activating the TFEB-Regulated #Autophagy-Lysosomal Pathway @FrontCellDevBio https://t.co/eSYGUP5czF

18 Dec 2020

Reply Repost Favourite

Multiple intriguing studies report direct GLP-1R-dependent reduction of hepatocyte steatosis, the latest here #NASH https://t.co/rU0pKZvw7j

18 Dec 2020

Reply Repost Favourite

New Research: Liraglutide Alleviates Hepatic Steatosis by Activating the TFEB-Regulated Autophagy-Lysosomal Pathway: Liraglutide, a glucagon-like peptide-1 receptor agonist (GLP-1RA), has been demonstrated to alleviate non-alcoholic fatty… https://t.co/QOO

28 Nov 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.